Arovella Therapeutics Limited

A$0.05As of Sun 8 Nov 2026, 12:00 UTC
ASX:ALAHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (18.78%)
Div yield —
ROE (40.41%)
Biotechnology
Beta (5Y) 0.14
PE TTM —
TSR TTM (45.11%)
Mkt cap A$61.05M
ROIC (28.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0582
15.18%
(67.12%)
Hold 3|11|3|4|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
(10.50%)
(7.96%)
(4.24%)
(3.45%)
Revenue$M
3.754
3.752
3.760
3.656
7.44%
10.43%
6.56%
2.52%
Peers (US$41.51M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
7.841
0.665
0.638
EBIT/Intx
0.559
0.086
0.090
Own earn%
5.26
87.84
105.60
Sh yield%
37.97
34.14
32.84
Owners
Insiders/Inst%
5.51
38.87
Short interest%
1.61
SBC / revenue%
0.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
8